Clinicopathological Characteristics of Mucinous Breast Cancer: A Retrospective Analysis of a 10-Year Study

por Lei, Lei, Yu, Xingfei, Chen, Bo, Chen, Zhanhong, Wang, Xiaojia
Publicado en PLoS One (2016)

Demethylation of miR‐195 suppresses prostate cancer cell proliferation, migration and invasion

por Ma, Xiaokun, Zou, Liyuan, Chen, Zhanhong, Li, Xing, Wei, Li, Wu, Xiangyuan
Publicado en FEBS Open Bio (2020)

Breast liposarcoma with solitary metastasis to the pleura: A case report

por Lei, Lei, Chen, Zhanhong, Wang, Zhuo, Zheng, Linfeng, Zheng, Yabing, Wang, Xiaojia, Wang, Xian
Publicado en Medicine (Baltimore) (2017)

Bioinformatics identification of dysregulated microRNAs in triple negative breast cancer based on microRNA expression profiling

por Chen, Junqing, Chen, Zhanhong, Huang, Jian, Chen, Feng, Ye, Weiwu, Ding, Guojun, Wang, Xiaojia
Publicado en Oncol Lett (2018)

Efficacy of Oxaliplatin/5-Fluorouracil/Capecitabine-Cetuximab Combination Therapy and Its Effects on K-Ras Mutations in Advanced Colorectal Cancer

por Wei, Li, Chen, Jie, Wen, Jingyun, Wu, Donghao, Ma, Xiaokun, Chen, Zhanhong, Huang, Jianglong
Publicado en Med Sci Monit (2020)

Expression of cluster of differentiation 34 and vascular endothelial growth factor in breast cancer, and their prognostic significance

por CHEN, ZHANHONG, XU, SHENHUA, XU, WEIZHEN, HUANG, JIAN, ZHANG, GU, LEI, LEI, SHAO, XIYING, WANG, XIAOJIA
Publicado en Oncol Lett (2015)

Prognostic significance of mammary Paget’s disease in Chinese women: a 10-year, population-based, matched cohort study

por Zhou, Huanhuan, Lu, Kongbeng, Zheng, Lei, Guo, Liwei, Gao, Yun, Miao, Xianyuan, Chen, Zhanhong, Wang, Xiaojia
Publicado en Onco Targets Ther (2018)

MicroRNA-126 Inhibit Viability of Colorectal Cancer Cell by Repressing mTOR Induced Apoptosis and Autophagy

por Wei, Li, Chen, Zhanhong, Cheng, Na, Li, Xing, Chen, Jie, Wu, Donghao, Dong, Min, Wu, Xiangyuan
Publicado en Onco Targets Ther (2020)

Exploring the concepts and practices of advanced breast cancer treatment: a narrative review

por Wang, Xiaojia, Shao, Xiying, Huang, Jian, Lei, Lei, Huang, Yuan, Zheng, Yabing, Cao, Wenming, Chen, Zhanhong
Publicado en Ann Transl Med (2021)

Long-term tolerance and cardiac function in breast cancer patients receiving trastuzumab therapy

por Huang, Ping, Dai, Shujun, Ye, Zhimin, Liu, Yajuan, Chen, Zhanhong, Zheng, Yabing, Shao, Xiying, Lei, Lei, Wang, Xiaojia
Publicado en Oncotarget (2016)

The CYP19 RS4646 Polymorphism IS Related to the Prognosis of Stage I–II and Operable Stage III Breast Cancer

por Shao, Xiying, Guo, Yong, Xu, Xiaohong, Zheng, Yabing, Wang, Jiwen, Chen, Zhanhong, Huang, Jian, Huang, Ping, Cai, Jufen, Wang, Xiaojia
Publicado en PLoS One (2015)

S4646 polymorphism in CYP19A1 gene is associated with the efficacy of hormone therapy in early breast cancer

por Shao, Xiying, Cai, Jinwei, Zheng, Yabing, Wang, Jiwen, Feng, Jianguo, Huang, Yuan, Shi, Lei, Chen, Zhanhong, Guo, Yong, Wang, Xiaojia
Publicado en Int J Clin Exp Pathol (2015)

Monitoring treatment efficacy and resistance in breast cancer patients via circulating tumor DNA genomic profiling

por Chen, Zhanhong, Sun, Tian, Yang, Ziyan, Zheng, Yabing, Yu, Ruoying, Wu, Xue, Yan, Junrong, Shao, Yang W, Shao, Xiying, Cao, Wenming, Wang, Xiaojia
Publicado en Mol Genet Genomic Med (2019)

Treatment after Progression on Fulvestrant among Metastatic Breast Cancer Patients in Clinical Practice: a Multicenter, Retrospective Study

por Xie, Yizhao, Zhao, Yannan, Gong, Chengcheng, Chen, Zhanhong, Zhang, Yinbin, Zhao, Yanxia, Yuan, Peng, Hu, Sainan, Li, Yi, Hu, Xichun, Zhang, Jian, Wang, Leiping, Wang, Biyun
Publicado en Sci Rep (2019)

Differences in the clinicopathological characteristics of pure and mixed invasive micropapillary breast carcinomas from eastern China

por Wang, Rong, Li, Nani, Wang, Xiao-Jia, Chen, Tianhui, Zhang, Hong, Cheng, Yongran, Sun, Wenyong, Chen, Zhanhong, Zheng, Yabing, Lizaso, Analyn, Chen, Songan, Cao, Wen-Ming
Publicado en Ann Transl Med (2021)

Rs1008805 polymorphism of CYP19A1 gene is associated with the efficacy of hormone therapy in stage I–II and operable stage III breast cancer

por Shao, Xiying, Luo, Lei, Guo, Yong, Xu, Xiaohong, Deng, Dehou, Feng, Jianguo, Ding, Yuheng, Mou, Hanzhou, Huang, Ping, Shi, Lei, Huang, Yuan, Ye, Weiwu, Lou, Caijin, Chen, Zhanhong, Zheng, Yabing, Wang, Xiaojia
Publicado en Oncol Lett (2017)

Albumin-to-Alkaline Phosphatase Ratio as an Independent Prognostic Factor for Overall Survival of Advanced Hepatocellular Carcinoma Patients without Receiving Standard Anti-Cancer...

por Cai, Xiurong, Chen, Zhanhong, Chen, Jie, Ma, Xiaokun, Bai, Mingjun, Wang, Tiantian, Chen, Xiangwei, Wu, Donghao, Wei, Li, Li, Xing, Lin, Qu, Wen, Jingyun, Ruan, Danyun, Lin, Zexiao, Dong, Min, Wu, Xiangyuan
Publicado en J Cancer (2018)

Ki67 and progesterone receptor status predicts sensitivity to palbociclib: a real-world study

por Shao, Xiying, Zheng, Yabing, Cao, Wenming, Shen, Xiabo, Li, Guangliang, Chen, Junqing, Huang, Yuan, Huang, Ping, Shi, Lei, Ye, Weiwu, Zou, Weibin, Lou, Caijin, Lei, Lei, Huang, Jian, Chen, Zhanhong, Wang, Xiaojia
Publicado en Ann Transl Med (2021)

Everolimus‐containing therapy vs conventional therapy in the treatment of refractory breast cancer patients with PI3K/AKT/mTOR mutations: A retrospective study

por Chen, Zhanhong, Zheng, Yabing, Cao, Wenming, Zhang, Yuzi, Zhao, Zhengyi, Wang, Guoqiang, Zhao, Jing, Cai, Shangli, Shao, Xiying, Huang, Jian, Ye, Weiwu, Huang, Yuan, Li, Wei, Huang, Xiang, Wu, Hao, Wang, Xiaojia, Yin, Yongmei
Publicado en Cancer Med (2019)